Two pancreatic-enzyme products approved

Two pancreatic-Enzyme products approved

(HealthDay) -- Two drugs that supplement the digestion-aiding actions of pancreatic enzymes have been approved by the U.S. Food and Drug Administration, the agency said Thursday in a news release.

Ultresa (pancrelipase) was approved for adults and children with and other disorders that affect food digestion because the pancreas does not produce enough enzymes, the FDA said.

The second drug, Viokace (pancrelipase), is to be used in combination with a to treat adults with pancreatitis. This drug's safety and effectiveness have not been established in children, the agency said.

About 200,000 people in the United States have "pancreatic insufficiency" disorders, according to the FDA. The two new medications are the fourth and fifth to be approved for these conditions.

Both new drugs are produced by Aptalis Pharma US, based in Bridgewater, N.J.


Explore further

Children now eligible for screening test for bacterium

More information: Medline Plus has more about pancreatic diseases.

Copyright © 2012 HealthDay. All rights reserved.

Citation: Two pancreatic-enzyme products approved (2012, March 2) retrieved 22 August 2019 from https://medicalxpress.com/news/2012-03-pancreatic-enzyme-products.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more